Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955653 · ClinicalTrials.gov registry record · NA
Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access
A NA study of Catheter Related Complication, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03955653: Completed NA study of Catheter Related Complication, sponsored by University of Alabama at Birmingham.
NCT03955653 is a NA study of Catheter Related Complication that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03955653, a NA study of Catheter Related Complication, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this proposed study is to examine if oblique projection (20- degrees right anterior oblique (RAO) for right femoral artery access or 20-degree left anterior oblique (LAO) for left femoral artery access) is superior to anterior projection (AP) for femoral artery access in zone 2-4 and thereby resulting in lower risk of access related complications.
Primary Outcome
We will assess the access to the center of the femoral artery after insertion of the sheath for heart catheterization or PCI
Conditions Studied
Interventions
- PROCEDURE Femoral artey access
Study Locations (1)
Alabama
- UAB - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-04-30 |
| Est. Completion | 2019-10-30 |
| Phase | NA |
What the finished NCT03955653 record still lists
NCT03955653 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Catheter Related Complication appearing as the primary indexed condition, and to 1 intervention - of which Femoral artey access is the first listed.
NCT03955653 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03955653 about?
NCT03955653 is a clinical study titled "Fluoroscopic-Guided Micropuncture Technique for Common Femoral Artery Access". The main objective of this proposed study is to examine if oblique projection (20- degrees right anterior oblique (RAO) for right femoral artery access or 20-degree left anterior oblique (LAO) for left femoral artery access) is superior to anterior projection (AP) for femoral artery access in zone 2...
What is the current status of trial NCT03955653?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-04-30. Estimated completion is 2019-10-30.
What conditions does trial NCT03955653 study?
This clinical trial studies the following conditions: Catheter Related Complication.
What interventions are being tested in trial NCT03955653?
The interventions under investigation include: Femoral artey access (PROCEDURE).
Who is sponsoring clinical trial NCT03955653?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03955653 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Catheter Related Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03955653's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI